Why every cancer is unique: Evolution, drug resistance, and the need for personalized treatments
By
Monika Joshi
A baker's-dozen of insight crammed into one ring.
Summary
This article explains cancer as an evolutionary disease, where genetic mutations and natural selection drive cancer development and drug resistance. It emphasizes that because every cancer is unique—shaped by different mutations, environments, and evolutionary pressures—there is no one-size-fits-all treatment approach. The article explores how understanding cancer evolution, including concepts like selective pressure and tumor heterogeneity, can help researchers develop more effective, personalized therapies and overcome drug resistance.
Key quotes
· 3 pulledCancer is an evolutionary disease. The same forces that turned dinosaurs into birds turn normal cells into cancer: genetic mutations and traits that confer a survival advantage.
There is no one-size-fits-all approach to treating cancer.
Understanding how cancer cells evolve could help researchers develop more effective drugs.
You might also wanna read
Study Reveals How Extrachromosomal DNA Drives Oncogene Evolution in Glioblastoma Tumors
This scientific study investigates how extrachromosomal DNA (ecDNA) drives oncogene spatial heterogeneity and evolution in glioblastoma. Res
aacrjournals.org·8mo ago
Scientists Develop Universal Cancer Vaccine Using mRNA Technology
Scientists have developed a 'universal cancer vaccine' using mRNA technology that can train the immune system to target any type of cancer,
newatlas.com·11mo ago
Emerging Evidence Challenges Traditional Views on Inheritance and Evolutionary Theory
The article examines emerging evidence challenging traditional evolutionary theory, particularly the long-held belief that acquired characte
aeon.co·4mo ago
Understanding Evolutionary Mismatch: How Modern Life Conflicts with Our Biology
The article explores the concept of 'evolutionary mismatch' - how modern life conflicts with our evolutionary biology, leading to issues lik
theguardian.com·8mo ago
Columbia Researcher Discovers Rare Genetic Mutation That Provides Universal Antiviral Immunity
Columbia University immunologist Dusan Bogunovic discovered that a rare genetic mutation causing immune deficiency in some patients also gra
cuimc.columbia.edu·9mo ago
Promising pancreatic cancer drug may unlock new class of treatments targeting cancer's master switch
The article discusses a promising new drug that targets pancreatic tumors and may have revealed a "master switch" for cancer. The treatment
economist.com·4d ago